poisar

Stocks · News reference

Inovio Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS results.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Bet on 4 Top-Ranked Stocks With Rising P/E

    The article explores how stocks with rising P/E ratios paired with accelerating earnings growth can deliver strong returns. Using specific screening criteria focused on earnings momentum and price performance, the analysis identifies four stocks: H World Group Limited (HTHT), Inovio Pharmaceuticals (INO), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI) as potential outperformers with consistent price gains and strong earnings surprises.

  2. Zacks Investment ResearchNa

    Bet on 5 Top-Ranked Stocks With Rising P/E

    The article explores how rising P/E ratios, combined with accelerating earnings growth and sustained price momentum, can indicate strong investment opportunities. Five stocks meeting these criteria are highlighted: CuriosityStream (CURI), Inovio Pharmaceuticals (INO), GDS Holdings (GDS), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI). These companies demonstrate consistent price gains relative to the S&P 500 and positive earnings trends.